Waters (WAT) Projected to Post Earnings on Tuesday

Waters (NYSE:WAT) is anticipated to release its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect Waters to announce earnings of $4.00 per share and revenue of $1.75 billion for the quarter. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Parties may visit the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:00 AM ET.

Waters (NYSE:WAT) last released its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. During the same period in the prior year, the firm posted $2.95 earnings per share. The business’s quarterly revenue was up 113.3% compared to the same quarter last year. On average, analysts expect Waters to post $14.56 EPS for the current fiscal year and $16.56 EPS for the next fiscal year.

Waters Trading Up 0.6%

NYSE WAT opened at $456.17 on Tuesday. Waters has a 12 month low of $282.77 and a 12 month high of $465.36. The company has a 50-day moving average of $425.31 and a 200-day moving average of $369.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 1.29. The company has a market cap of $44.82 billion, a P/E ratio of 113.76, a P/E/G ratio of 2.64 and a beta of 1.15.

Insider Activity

In related news, Director Christopher Kuebler sold 3,626 shares of Waters stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the transaction, the director owned 17,808 shares in the company, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.31% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

WAT has been the topic of several research analyst reports. TD Cowen raised their target price on shares of Waters from $475.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Royal Bank Of Canada upped their price target on shares of Waters from $435.00 to $475.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Jefferies Financial Group upped their price target on shares of Waters from $450.00 to $455.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Stifel Nicolaus set a $420.00 price target on shares of Waters in a research note on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Waters from a “hold” rating to a “buy” rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $457.50.

Waters Company Profile

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.